|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 31/485 | |
| A61K 9/20 | |||
| A61P 25/04 |
| (11) | Patento numeris | 1404331 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 02744835.6 |
| Europos patento paraiškos padavimo data | 2002-07-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-04-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2007-10-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2002/021403 |
| Data | 2002-07-03 |
| (87) | Numeris | WO 2003/004033 |
| Data | 2003-01-16 |
| (30) | Numeris | Data | Šalis |
| 303357 P | 2001-07-06 | US | |
| 329352 P | 2001-10-15 | US | |
| 329426 P | 2001-10-15 | US |
| (72) |
BAICHWAL, Anand, R., US
KAO, Huai-Hung, US
MCCALL, Troy, W., US
|
| (73) |
Penwest Pharmaceuticals Co.,
2981 Route 22, Patterson, NY 12563-9970,
US
|
| (54) | SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |
| SUSTAINED RELEASE FORMULATIONS OF OXYMORPHONE |